Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
Do you employ a phrenic nerve dose constraint with conventional fractionation?
E.g. breast or H&N cancers when boosting the supraclav area.
Answer from: Radiation Oncologist at Community Practice
No.
Sign in or Register to read more
14494
Related Questions
What dose and regimen would you treat a stage I laryngeal cancer s/p R1 resection?
When would you consider larynx preservation in patients with T4N+ SCC of the larynx?
How do you approach postoperative radiation therapy in a patient with head and neck cancer who has high risk of recurrence in the setting of active epidermolysis bullosa?
How do you treat SNUC?
What alternatives do you recommend for oral dexamethasone solution for HN cancer?
What dose would you use for a plaque brachytherapy for a melanoma involving the iris?
Do you recommend radioactive iodine for Hürthle Cell thyroid carcinoma?
What are your top takeaways in Head & Neck Cancers from ASTRO 2024?
Is there a role for reirradiation for SCC oral tongue with high-risk features (i.e., PNI, close margins) following surgery?
Is there a role for prophylactic Trental and vitamin E in a patient at high risk for osteoradionecrosis?